Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin on Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-Label, Blinded Endpoint Parallel-Group Comparison Study
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-034883
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2020
Authors
Publisher
BMJ